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The baculovirus expression system is one of the most successful and widely used eukaryotic protein expression methods. This
short review will summarise the role of bacterial artiﬁcial chromosomes (BACS) as an enabling technology for the modiﬁcation
of the virus genome. For many years baculovirus genomes have been maintained in E. coli as bacterial artiﬁcial chromosomes,
and foreign genes have been inserted using a transposition-based system. However, with recent advances in molecular biology
techniques, particularly targeting reverse engineering of the baculovirus genome by recombineering, new frontiers in protein
expression are being addressed. In particular, BACs have facilitated the propagation of disabled virus genomes that allow high
throughput protein expression. Furthermore, improvement in the selection of recombinant viral genomes inserted into BACS has
enabled the expression of multiprotein complexes by iterative recombineering of the baculovirus genome.
1. BaculovirusProteinExpression
1.1. Baculoviruses. The Baculoviridae is a family of viruses
with a circular dsDNA genome, ranging in size from
80kb to 180kb, that infect arthropods. Virus particles
are rod-shaped, with a lipid envelope derived from the
host cell. The family is divided into four genera, based
on the comparison of a subset of core genes conserved
between all baculoviruses [1, 2]. The viruses used for
recombinant protein expression are Autographa californica
multiple nucleopolyhedrosis virus(AcMNPV) and Bombyx
mori nucleopolyhedrosis virus(BmNPV) and both are in the
Alphabaculovirus genus. Both viruses are pathogens of the
larval stages of lepidopteran species and have an infection
cycle that involves ingestion and infection of the cells of
the mid-gut, followed by systemic infection. In contrast
to vertebrate herpesviruses, which have a similarly sized,
circular DNA genome, and which are largely cryptic infec-
tions except in immunocompromised individuals, infection
of caterpillars with AcMNPV and BmNPV results in a short
duration, acute, systemic infection with liquefaction of the
host (Figure 1). Once the host is liqueﬁed, the virus remains
in the environment encased in a protein matrix formed from
the virally encoded polyhedrin protein until it is ingested
by the next caterpillar and the alkali environment of the
insect mid-gut triggers dissociation of the polyhedrin coat
and release of the virus [3, 4].
Reﬂecting the complex nature of their genome, bac-
ulovirus infections have a complex multiphase replication
cycle that involves a distinct series of transcriptional steps.
AcMNPV enters the host cell by a fusion process, mediated
by the GP64 protein on the virus surface [5–10], and the
nucleocapsid is traﬃcked to the nucleus. The virus has
a genome of 133 894bp double-stranded (ds) DNA and
encodes 154 putative ORFs [11]; following nuclear entry,
some of the corresponding genes are transcribed by the
h o s tR N Ap o l y m e r a s eI Ia n da r et e r m e di m m e d i a t ee a r l y
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Figure 1: Key stages in the infection cycle of AcMNPV. (A)
Infection is initiated by the ingestion of a virus occlusion body
(OB).Thisconsistsofmultiplevirusnucleocapsidssurroundedbya
single lipid envelope (ODV) embedded in a protein matrix formed
by the virally encoded polyhedrin protein. (B) The occlusion body
is dissolved by the alkaline environment of the insect mid-gut,
releasing ODV which initiate a primary infection in the midgut
epithelial cells. (C) Virus enters cells and replicates in the nucleus.
Two diﬀerent forms of infectious virus are produced in infected
cells. Budded virus (BV) is released at the cell surface and mediates
systemic infection of the insect via the tracheal system, and ODV
remains embedded in occlusion bodies. (D) Late stages of virus
infection trigger liquefaction of the host, releasing the environmen-
tally stable proteinaceous occlusion bodies. Polyhedrin protein is
nonessential for the infection of cells in continuous culture in the
laboratory and its high level of synthesis makes its promoter ideal
for the high-level production of recombinant protein.
including some that act as transactivators for the expression
of other viral genes that start to be produced late (6–12
hours) and very late (16–76 hours) post-infection [12–20].
Two forms of mature virus particles are produced in infected
cells: budded virus is released from the cell from about 8
hours post-infection [21, 22] and is responsible for cell-to-
cell spread within the infected caterpillar. Occluded virus
is produced later in infection and is the form of the virus
preserved in polyhedra, and is responsible for infection of
the next host.
With a few exceptions early in infection, there is a global
down-regulation of cellular transcription in baculovirus-
infected cells [23–25]. The molecular basis for how this is
mediated is unclear, but given the number of genes aﬀected
(mRNA corresponding to >10,000 ESTs is transcriptionally
downregulated within 12 hours post-infection [25]), this
is unlikely to be a targeted programme of downregulation.
The consequence of transcriptional shutdown is that cellular
protein levels deteriorate in baculovirus infections between
10–12 hours postinfection and cell lysis usually occurs some-
time after 76 hours postinfection. AcMNPV overcomes this
transcriptional downregulation by expressing its own DNA-
dependent RNA polymerase complex, which is responsible
for the transcription of late and very late genes [26–33].
Coupled to a high gene copy number as a result of the
replication of the virus genome, this polymerase potentiates
high level synthesis of recombinant protein. The polyhedrin
protein accumulates to high levels in infected cells and
polyhedra can represent up to 30% of the dry weight of
infected caterpillars [34]. A lot of the initial and continuing
interest in baculoviruses is related to their potential as
environmentally safe, targeted, biopesticides for the control
of insect pests [34–37]. However, AcMNPV and BmNPV are
also widely used in academic and industrial research and
biopharmaceutical production.
1.2. Production of Recombinant Proteins in the Baculovirus
System. Early experiments in protein expression using the
baculovirus genome as a vector were based on the replace-
ment of the coding sequence for the polyhedrin protein
with another gene. This approach has two advantages;
ﬁrstly, it capitalises on the very high expression level usually
observed for polyhedrin. Secondly, as polyhedra are readily
observed under a light microscope in cells that express
native polyhedrin, recombinant viruses can be selected
based on a polyhedra negative phenotype, allowing for
selection of pure recombinant virus stocks. As the virus
genome was too large for routine direct manipulation at
that time, early protein expression studies took advantage
of the fact that homologous recombination in baculovirus-
infected insect cells is relatively eﬃcient. Replication of the
baculovirus genome involves expression of proteins that pro-
mote homologous recombination [38, 39]. Transfer vectors
were constructed in which an expression cassette was ﬂanked
with regions homologous to sequences in the baculovirus
genome. Cotransfection of the transfer vector and virus
DNA into insect cells allowed selection of recombinant
virus. The ﬁrst recombinant protein successfully expressed
to high levels using this approach was human beta interferon
[40]. Subsequent modiﬁcations to this system included the
insertion of the LacZ coding sequence into the polyhedrin
locus of the virus genome to allow blue-white screening
and linearization of the genome in an adjacent essential
gene; both modiﬁcations facilitated selection of recombinant
viruses [41–43]. The use of dual promoter vectors for the
expression of LacZ, another protein from the polyhedron,
and one other genetic locus (p10 locus) within the virus
genome was also demonstrated [44–46].
Perhaps the best demonstration of the utility of recom-
binant protein production using the baculovirus system is
by its widespread use. A search of PubMed with the terms
“((baculovirus OR AcMNPV) AND recombinant protein)”
returns 7281 peer-reviewed publications, between the initial
description of human interferon expression in 1983, and
December 2011 (Figure 2). There are now several other
eukaryotic systems that are used for the expression of
recombinant proteins but the baculovirus system remains aISRN Microbiology 3
1
9
8
3
1
9
8
4
1
9
8
5
1
9
8
6
1
9
8
7
1
9
8
8
1
9
8
9
1
9
9
0
1
9
9
1
1
9
9
2
1
9
9
3
1
9
9
4
1
9
9
5
1
9
9
6
1
9
9
7
1
9
9
8
1
9
9
9
2
0
0
0
2
0
0
1
2
0
0
2
2
0
0
3
2
0
0
4
2
0
0
5
2
0
0
6
2
0
0
7
2
0
0
8
2
0
0
9
2
0
1
0
2
0
1
1
Year
600
500
400
300
200
100
0
P
u
b
l
i
c
a
t
i
o
n
s
 
p
e
r
 
y
e
a
r
Figure 2: Annual publications 1983–2011 containing the search terms baculovirus or AcMNPV and recombinant protein.
popular choice with 233 and 261 publications with the same
search terms in 2009 and 2010, respectively. Recombinant
proteinsexpressedrangefromsmallpeptidestomultiprotein
complexes assembled from multiple subunits [47–50]. As
expression is in eukaryotic cells, recombinant proteins have
authentic posttranslational processing with respect to phos-
phorylation, palmitoylation, isoprenylation, myristoylation,
and folding [51–54]. Glycoproteins expressed in the system
are also usually modiﬁed by the addition of carbohydrates
by the N-glycosylation pathway, but the insect cells used
generally lack the capability to synthesize the terminal highly
branched galactose and sialic acid carbohydrates found on
proteins expressed in mammalian cells [55]. These problems
can be overcome to a certain extent by using modiﬁed cells
engineered to express enzymes in the human glycosylation
pathway [56–58].
2. EarlyUseofBacterialArtiﬁcialChromosomes
inthe BaculovirusSystem
While the selection of viruses produced by homologous
recombination in insect cells was a highly eﬀective way to
recover recombinant viruses, it required a reasonable level
of training in virology in order to be able to complete
routinely. The development of baculovirus genomes in
which a bacterial artiﬁcial chromosome (BAC) sequence and
transposon target site were inserted at the polyhedrin locus
in the virus genome allowed the propagation of the virus
genome in E. coli as a bacmid [59]. This system allowed
the transposition of a short sequence of DNA containing
the promoter for the polyhedrin gene, a coding sequence,
and a polyadenylation signal sequence into the BAC DNA
located at the polyhedrin locus of the AcMNPV genome.
The system was designed such that successful transposition
interrupted the coding sequence of the LacZα fragment,
allowing selection of recombinants in E. coli by standard
blue-white screening. This removed the need for plaque
selection of recombinant viruses, which made the system
more accessible to non-virology laboratories. The bacmid
system was successfully marketed by Invitrogen as “Bac-to-
Bac”andhasbeenadoptedbymanylaboratoriesasamethod
for the eﬃcient production of recombinant baculovirus.
Notable variations on this core technology include the
introduction of an antibiotic resistance gene expressed in E.
coli with the transposed element, and the inclusion of the
sacB gene on the transfer vector, to select for recombinant
bacmid and counter-select the transfer vector which has not
recombined, respectively [60]. These variations allow high-
throughput selection of recombinants produced using the
core approach.
Since the initial description of application of the bacmid
technology to AcMNPV, the approach has since been applied
tootherrelatedbaculoviruses[61–64].Inmostcases,therole
of the BAC modiﬁed virus genome has been to provide a
stable reference genome for sequencing studies. But in the
case of BmNPV, a similar protein expression system to the
more widely used AcMNPV system has also been developed.
3.Recent Developments inBaculovirus
Research Enabledby BACs
3.1. Improved Understanding of Baculovirus Biology. In addi-
tion to facilitating insertion of foreign coding sequences into
the baculovirus genome, maintenance of the virus genome
as a bacmid in E. coli has also enabled the use of advanced
reverse engineering approaches. In particular, the use of
the recET/lambda-red-based recombineering approach [65]
has been enthusiastically adopted by laboratories frustrated
with the problem of producing null mutants in virus genes
using conventional approaches. The core problem is that
disruption of scientiﬁcally interesting genes often results
in the production of a virus that has low or no viability.
With conventional techniques, the generation of mutations
in these genes either relied on conditional mutants [66,
67] or recombination in insect cells where mutations were
complemented with transgenes in the virus or cellular
genome [8, 68, 69]. Although eﬀective, these approaches
were time consuming and, in some cases, failed to recover
the required mutation [70].
The great advantage of the BAC platform as a basis of
mutagenesis is that recovery of the mutant genome does
not rely on the ability of the virus to replicate in insect
cells, only on the viability of the BAC sequence. Therefore,
there is a similar potential for mutagenesis by homologous
recombination as in insect cells, but it is possible to4 ISRN Microbiology
separate out failure of the resulting virus to replicate from
failure of the recombination reaction. Bideshi and Federici
ﬁrst reported application of recET-based recombination to
generate deletion mutants in the AcMNPV bacmid [71]
using the E. coli strain BJ5183 [72]. This mutation involved
the disruption of the AcMNPV helicase gene; subsequent
studies have used similar approaches for the disruption of a
range of genes involved in a number of other virus functions
(Table 1). The approach has been particularly useful to
characterise mutations involved in virus assembly and cell-
to-cell spread, where release of the infectious virus can be
separated from genome replication.
To date, ∼25% (40 out of an estimated 156) AcMNPV
genes have been disrupted using the ET recombination
method, demonstrating its utility for the routine modi-
ﬁcation of viral genomes maintained as bacmids. Similar
approaches have been used with BmNPV [73, 74]a n dw i t h
other dsDNA viruses that can be maintained as bacmids in
E. coli, including herpesviruses [75–81]. Therefore, the BAC
r e c E Ts y s t e mi sb e c o m i n gav a l u a b l ea p p r o a c ht h a th a sb e e n
usedtoaid in theunderstanding themechanism ofinfection,
assembly, replication, and host interaction of a broad range
of diﬀerent viruses.
3.2. Improved Quality of Biopharmaceuticals. One of the
problems with using baculovirus-based systems for the
production of biopharmaceuticals has been the consequence
that a live virus is used in the protein production process
and must be puriﬁed away from any recombinant protein
produced. Although baculoviruses are naturally present at
high quantities in the environment and AcMNPV is easily
inactivated with nonionic detergents and binary ethylen-
imine [82] and does not replicate in vertebrate cells [83, 84],
removal of baculovirus and its DNA from protein products
is generally required prior to licensing. One recent approach
used an insect cell line expressing AcMNPV VP80 from a
transgeneintegratedintothecellularchromosomalDNAand
a bacmid-derived AcMNPV vp80 null mutant [22]. As VP80
isessentialforthematurationofthevirusnucleocapsidinthe
nucleus [85], the null mutant wasonly able to produce viable
progeny viruses in the complementing cell line. This cell line
wasusedforampliﬁcationofthevirusesandanontransgenic
cell line used for protein expression to recover recombinant
protein free of viable baculovirus.
3.3. Recombineering for High-Throughput Production of Pro-
teins. In addition to improving understanding of the virus
biology, the bacmid platform, coupled to recET mutage-
nesis, has also been applied to improving the baculovirus
system for protein production. Although many recombinant
baculoviruses capable of expressing recombinant protein
have been generated with the BAC-Tn7 transposase-based
system [86], there are indications that genes inserted into
the polyhedrin locus of the virus genome using this system
are unstable, with recombinant protein expression declin-
ing with passage number [61, 87]. Although this can be
addressed by genetic linkage of transgenes with sequences
that promote retention of the foreign gene sequences, [88,
Table 1: Summary of null mutants in AcMNPV generated in
BACmid DNA by ET recombination.
Virus function Gene deleted References
DNA replication helicase (p143), lef3, lef5,
lef6, lef11, alk-exo, dna-pol
[70, 71,
94–100]
Transcription ie-0 and ie-1 [101]
Cell entry ac23, gp64 [47, 102,
103]
Infectivity in insects ac96, p74 [104, 105]
Nucleocapsid assembly p6.9, ac53, vlf-1, 38K,
ac101, ac142, ac144, ac109 [106–112]
Nucleocapsid release from
the nucleus exon0, ac66, vp80 [22, 85,
113–115]
Formation of enveloped
virus
ac142, p48, ac76, odv-e18,
odv-e56
[47, 116–
118]
Interaction with host egt, chiA, v-cath, IAP2 [47]
Unknown, essential genes ac92, ac-fgf, ac11, ac-pe [47, 119]
Unknown, non-essential
genes me53, ac18, ac-ctx [47, 120,
121]
89] some laboratories maintain that insertion of genes
directly into the AcMNPV genome in insect cells results in
more stable protein expression. One of the problems with
the latter approach has always been that recombination in
insectcellsrequiredbothaviablevirusgenomeandasuitable
transfer vector. Therefore, the viable virus genome inevitably
led to a proportion of parental virus genomes that did not
express the foreign gene and the approach was not suitable
for high-throughput protein production.
Theproblemofselectionofrecombinantviruseswaspar-
tiallysolvedbyKittsetal.[42,90],whodevelopedtechniques
allowing selection of recombinant baculovirus using lin-
earised virus DNA and lacZ expression. However, although
it was a signiﬁcant improvement on previous approaches,
there was still a residual background of replicating viruses.
The problem was ﬁnally solved by Zhao et al. [91], who used
the bacmid-based recET recombineering system to make a
deletion in an essential gene (orf1629) for virus replication
in insect cells that is located next to the polyhedrin locus.
This mutation was only possible because the defective viral
genome could be maintained in E. coli as a bacmid. As
the virus genome could only replicate in insect cells once
recombination with the transfer vector had occurred, the
problem of background virus replication was eliminated.
In practice, there is probably a low level of replication
of the defective genome through complementation unless
virus genomes are puriﬁed by plaque-cloning methods.
However, this is not signiﬁcant enough to interfere with
most high-throughput applications. Recent developments
to this approach have combined the knockout deletion in
orf1629 with deletions of chiA, v-cath,a n dp10 genes, with
the aim of improving expression levels and traﬃcking of
recombinant proteins [92, 93]. These modiﬁed defective
genomes are commercially available as ﬂashBac (Oxford
Expression Technologies, UK) and BacMagic (Merck).ISRN Microbiology 5
4. EngineeringStable Expressionof
ProteinComplexes
Although many protein expression experiments focus on
the production of one speciﬁc recombinant protein, there is
an increasing recognition that many, if not most, biological
processes are completed by complexes formed of several
interacting proteins. In response, there is an increasing
focus on the expression and puriﬁcation of these com-
plexes using recombinant systems. The AcMNPV based-
baculovirus expression system has proved to be particularly
useful for the expression of functional complexes [49, 122–
124]. As a eukaryotic system, baculovirus-based expression
has all the appropriate chaperones and other posttransla-
tional modiﬁcation activities that facilitate the assembly of
large and complex protein assemblies.
The most straightforward approach to the production
of protein complexes using the baculovirus system is the
co-infection of the same batch of cells with two or more
recombinant baculoviruses, each expressing a diﬀerent for-
eign protein. The principle is that cells coinfected with the
two viruses will express all the foreign proteins, allowing
assembly of the complex. This approach has been used
successfully for the production of many complexes and is
often used to assess the potential for proteins to interact
to form complexes [125–128]. However, as a method to
reproducibly synthesize optimal amounts of recombinant
protein, it is reliant on careful titering of infectious virus and
cell numbers as the relative proportion of individual viruses
presentineachcellisdeterminedbythePoissondistribution.
This, in eﬀect, means that a batch of cells infected with
multiple viruses actually consists of multiple subpopulations
in which the ratio of expression of diﬀerent subunits in
the complex varies. Furthermore, there is evidence that the
Poisson distribution alone may not be suﬃcient to explain
all variation in the level of subunit expression, and that
infection with large numbers of diﬀerent viruses per cell
may inhibit protein expression [129]. An approach that
circumvents these problems is to express multiple proteins
from the same virus backbone so that all infected cells
produce the recombinant proteins at the same relative ratio.
Transfer vectors allowing the expression of multiple proteins
from the same baculovirus genome were ﬁrst constructed
some time ago [130–133]. However, due to the need to insert
multiple genes into the same vector, and the fact that the
uppersizeofthevectorrestrictsthenumberofgenesthatcan
be inserted, cloning strategies for these vectors, especially for
large complexes, are not straightforward.
The ﬁrst attempt to address this problem, based on the
manipulation of bacmid DNA was by Berger et al. [134].
In these experiments, a LoxP recombination target site was
inserted at the position of the chiA and v-cath genes that
are adjacent in the baculovirus genome in the bacmid,
using the recET recombineering approach. As the bacmid
already contained the Tn7 transposase target site, the LoxP
site allowed insertion of foreign genes at a second locus
by Cre-mediated recombination. The resulting system is
referred to as “Multibac” in the literature. The advantage
of this system is that it is possible to “mix and match”
the sequences inserted at the polyhedrin and chiA-v-cath
loci [135, 136]. By combining with transfer vectors that are
modiﬁed to allow repeated insertions of dual expression
cassettes by conventional ligation or ligation-independent
cloning approaches, expression of multiple protein subunits
from the same baculovirus is possible [134, 135]. This
partially solves the problem of large transfer vectors as genes
are split between two loci, eﬀectively doubling the limit
imposed by maximum transfer vector size. Furthermore, as
the system was developed speciﬁcally to allow automation of
proteinproductionbyrobotics,manydiﬀerentcombinations
of subunits can be rapidly tested for any one complex, which
isparticularlyusefulforstructuralstudies[135].Althoughin
principlethissystemcanbeusedfortheexpressionofprotein
complexes with a large number of diﬀerent subunits, early
experiments suggested that there was some genetic instabil-
ity, possibly due to repeated DNA elements [136]. This was
not supported in subsequent experiments which suggested
that 5 diﬀerent recombinant proteins were still expressed
after 4 low multiplicity of infection in vitro passages in 90%
of cells [135]. However, studies on transposon insertions
with a single insert predict that eﬀects of gene deletion in
baculovirus experiments may not be apparent before 5–10
passages anyway [87]. Overall, there is no clear evidence that
inserts in the modiﬁed system are any less stable than the
original Tn7 transposase-based bacmid system [59].
An alternative system for the production of multiprotein
complexes from baculovirus genomes engineered to co-
express protein subunits avoids both the transfer vector
size problem and the potential for genetic instability in
insect cells [47]. Instead of using site-speciﬁc transposase or
recombinase activities to integrate genes into the baculovirus
genome, the approach takes advantage of improved selection
of recombinants to use the recET recombineering approach
to directly insert cassettes for foreign gene expression at
diﬀerent genetic loci in the baculovirus genome (Figure 3).
In order for the BAC-based recET approach to be viable
for the routine insertion of genes for protein expression, it
was necessary to signiﬁcantly improve the ease with which
recombinants could be selected. To achieve this, a bipartite
selection system that allowed at least a 21-fold increase in the
eﬃciency of selection of recombinants was developed [47].
Bycouplingthis selection to self inactivating loxPsites, it was
possible to achieve iterative modiﬁcations at multiple sites in
the same genome using the same selection. Using this system
coexpression of protein complexes containing two, four, and
diﬀerent recombinant proteins was demonstrated.
5. Conclusions andFuturePerspectives
The use of bacterial artiﬁcial chromosomes continues to
have a major impact on the development of studies for
baculovirus and other large DNA viruses. Coupled to the
recET recombineering approaches [65, 137, 138], the BAC
platform is a powerful tool for understanding both the basic
biology and for developing the industrial applications of
baculovirus systems. The combination of null mutants with
complementation has provided interesting insights into the6 ISRN Microbiology
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(b)
Figure 3: Iterative modiﬁcation of AcMNPV to insert multiple
single-locus expression cassettes. (a) Strategy used for repeated
modiﬁcation of the same bacmid to express multiple diﬀerent
recombinant proteins. ET recombination is targeted by viral
ﬂanking sequences (VF) to homologous sequences in the bacmid.
Selection in E. coli is achieved using a bipartite marker consisting
of a Zeocin resistance (Z
R) and LacZα (Z), ﬂanked by partially
defective loxP sites. Following Cre-mediated recombination, this
marker is removed, allowing a subsequent modiﬁcation of the same
DNA. (b) Loci within the AcMNPV successfully modiﬁed using the
iterative modiﬁcation strategy.
role of viral proteins in virus replication, host interaction,
and assembly. Current studies have been relatively crude and
have resulted in deletions in the virus genome. As genes are
arranged in both directions on the circular dsDNA AcMNPV
genome, the impact of these deletions on ﬂanking genes is a
potentialproblem.Futurestudiesmayverywellinvolvemore
seamless modiﬁcation of the virus genome.
In terms of the applied use of baculovirus systems, BACs
have facilitated protein expression for a number of years.
The new recombineering approaches have also opened up
new ways to produce virion-free biopharmaceuticals [22],
and for the eﬃcient production of multiprotein complexes
[47, 134]. However, these are only beginning to scratch
the surface of what is now possible with the baculovirus
system. The demonstration that the routine integration of
transgenes at any locus in the AcMNPV genome is now
possible [47] opens the possibility of modifying background
genomes to facilitate the expression environment for speciﬁc
recombinant proteins.
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